Skip to main content
AYTU BIOPHARMA, INC logo

AYTU BIOPHARMA, INC — Investor Relations & Filings

Ticker · AYTU ISIN · US0547548745 US Manufacturing
Open in API
Filings indexed 890 across all filing types
Latest filing 2023-08-16 Director's Dealing
Country US United States of America
Listing US AYTU

About AYTU BIOPHARMA, INC

https://aytubio.com/

Aytu BioPharma, Inc. is a specialty pharmaceutical company focused on developing and commercializing novel therapeutics. The company concentrates on advancing innovative medicines for complex central nervous system (CNS) diseases, with a particular emphasis on treatments for Attention-Deficit/Hyperactivity Disorder (ADHD) and Major Depressive Disorder (MDD). Its business model involves identifying, acquiring, and commercializing new products to improve the quality of life for patients with unmet medical needs.

Recent filings

Filing Released Lang Actions
Director's Dealing 2023
Director's Dealing
2023-08-16 English
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 11, 2023, by Aytu BioPharma, Inc. The key content is under Item 5.02, which reports the approval of bonuses for named executive officers by the Compensation Committee. This relates to changes or announcements about executive compensation and management. There is no financial report, earnings data, or detailed management discussion. The document is primarily an announcement of management-related information, specifically about executive bonuses. Therefore, it fits best under Board/Management Information (MANG). The document length is 3378 characters, which is short and consistent with a Form 8-K announcement rather than a full report. Hence, the classification is MANG with high confidence.
2023-08-15 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events or disclosures by a company. The text includes a press release about an exclusive agreement, attached as an exhibit, and explicitly states that the information is not filed for purposes of Section 18 and is not incorporated by reference into other filings. The document length is 3645 characters, which is relatively short and mainly serves as an announcement rather than a full report. There are no financial statements or detailed financial data included. The content fits the description of a Regulatory Filing (RNS), which is a general regulatory announcement and a fallback category for filings that do not fit other specific categories. Therefore, the appropriate classification is Regulatory Filings (RNS).
2023-07-31 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text includes a press release about a manufacturing site transfer submission, attached as an exhibit. The document is short (3570 characters) and primarily serves as an announcement of this event and the press release, not a detailed financial report or other specific filing. It does not contain financial statements or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2023-07-10 English
Director's Dealing 2023
Director's Dealing
2023-07-06 English
FORM S-8
Regulatory Filings Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used for registering securities to be offered under employee benefit plans such as equity incentive plans. It includes incorporation by reference to other filings like 10-K, 10-Q, and proxy statements but does not itself contain financial statements or earnings data. It is a regulatory filing related to securities registration rather than a financial report or announcement of voting results, management changes, or capital updates. Therefore, it fits best under the category of Regulatory Filings (RNS). The document length is substantial (15,000 characters), indicating it is not a brief announcement but a full registration statement.
2023-06-23 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.